Biomarkers – Webinars and Online Events

In this webinar, our expert speakers will discuss how to optimize glycopeptide analysis using capillary liquid chromatography coupled to tandem mass spectrometry, showcasing how the ZenoTOF 7600 system enhances the analysis of proteins and their post-translational modifications.

Join our webinar, hosted by Klaus Hochleitner, to discuss key considerations for lateral flow test development and optimization and troubleshooting techniques for different samples, tests and antibodies.

In this webinar, two expert speakers will showcase how accurate mass diagnostic fragments of fentanyl and other analogs can be utilized to identify new fentanyl analog biomarkers.

In this webinar, Dr. Roberts will highlight how his work aims to identify disease-specific lipid isomers that can be used for the early detection and diagnosis of PD, using ion mobility mass spectrometry.

During this webinar, you will discover ways to improve your protein extraction, such as by reducing workflow complexity, improving results from scarce samples, setting up robust assays and working with large sample cohorts.

Speaking at Proteomics & Metabolomics 2022, Mohit Jain from Bruker, presented their talk on small molecule biomarkers in drug development.

This symposium brings together world-leading experts in cancer research and translational medicine to showcase how nanopore sequencing technology is being utilized to identify novel disease biomarkers.

From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.

The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.

Attend this webinar to:
- Overcome key challenges when working with rare antigen-specific T cells
- Learn the key considerations when preparing samples for single-cell sequencing
- Gain insights into tumor single-cell sequencing results

The tumor microenvironment (TME) is a heterogenous network of various cell types and structural elements. Understanding cell interactions and biological processes within the TME offers possibilities for the development of improved and personalized therapies.

Imaging multiple biomarkers in a single tissue section combined with analysis of their spatial information within the TME enables deep phenotyping and biomarker discovery and can help improve cancer therapy.

In this webinar, we present the unique MACSima™ imaging cyclic staining (MICS) technology from Miltenyi that automates the imaging of hundreds of biomarkers and the associated software that has been specifically developed to analyze multidimensional datasets.

Preclinical models are crucial to studying the association between molecular features of tumor cells and response to chemical perturbations. However, only a few predictors of drug responses have been successfully translated to clinical settings.